New cholesterol lowering agent after myocardial infarction?

被引：0

|

作者：

Rostadmo, Martine

机构：

来源：

TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING | 2015年 / 135卷 / 17期

关键词：

D O I：

10.4045/tidsskr.15.0759

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：1548 / 1548

页数：1

相关论文

共 50 条

[1] THE VALUE OF LOWERING CHOLESTEROL AFTER MYOCARDIAL-INFARCTION
ROSSOUW, JE
LEWIS, B
RIFKIND, BM
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (16): : 1112 - 1119
[2] Use of cholesterol-lowering therapy by elderly adults after myocardial infarction
Ayanian, JZ
Landrum, MB
McNeil, BJ
ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (09) : 1013 - 1019
[3] Alirocumab for intensified Lowering of Cholesterol in Patients with Myocardial Infarction
Krome, Susanne
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2022, 147 (16)
[4] Lipid-lowering therapy after myocardial infarction: The Bavarian cholesterol screening project
Richter, WO
Schwandt, P
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (07): : 603 - 604
[5] Study finds increased use of cholesterol-lowering drugs after myocardial infarction
不详
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2002, 59 (12) : 1148 - 1148
[6] LOVASTATIN - A NEW CHOLESTEROL-LOWERING AGENT
KRUKEMYER, JJ
TALBERT, RL
WEINER, B
BERRY, NS
BAUMAN, JL
PHARMACOTHERAPY, 1987, 7 (06): : 198 - 210
[7] LOVASTATIN - A NEW CHOLESTEROL-LOWERING AGENT
MCKENNEY, JM
CLINICAL PHARMACY, 1988, 7 (01): : 21 - 36
[8] Alirocumab for intensified Lowering of Cholesterol in Patients with Myocardial Infarction Comment
Laufs, Ulrich
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2022, 147 (16) : 1026 - 1027
[9] Cholesterol-lowering therapy after acute myocardial infarction in a low coronary risk population
Andrikopoulos, G
Richter, D
Zairis, M
Needham, E
Grammatopoulos, D
Foussas, S
Mattu, R
Stefanadis, C
Gialafos, J
Toutouzas, P
EUROPEAN HEART JOURNAL, 2000, 21 : 702 - 702
[10] PLASMA CHOLESTEROL AFTER MYOCARDIAL INFARCTION
COTTON, SG
POSTGRADUATE MEDICAL JOURNAL, 1970, 46 (539) : 551 - +

← 1 2 3 4 5 →